Hospira Aztreonam for Injection USP 2 gram/vial

País: Austrália

Língua: inglês

Origem: Department of Health (Therapeutic Goods Administration)

Ingredientes ativos:

aztreonam, Quantity: 2.094 g

Disponível em:

Hospira Australia Pty Ltd

Forma farmacêutica:

Injection, powder for

Composição:

Excipient Ingredients: arginine

Via de administração:

Intramuscular, Intravenous Infusion, Intravenous

Unidades em pacote:

10 x 30 mL

Tipo de prescrição:

(S1) This Schedule is intentionally blank

Indicações terapêuticas:

Aztreonam for Injection is indicated for the treatment of the following infections caused by susceptible Gram negative microorganisms: Urinary Tract Infections (complicated and uncomplicated), including pyelonephritis and cystitis (initial and recurrent) caused by Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, Pseudomonas aeruginosa, Enterobacter cloacae, Klebsiella oxytoca, Citrobacter species, and Serratia marcescens. Lower Respiratory Tract Infections, including pneumonia and bronchitis caused by Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, Haemophilus influenzae, Proteus mirabilis, Enterobacter species, and Serratia marcescens. Septicemia caused by Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, Proteus mirabilis, Serratia marcescens, and Enterobacter species. Skin and Skin Structure Infections, including those associated with postoperative wounds, ulcers, and burns, caused by Escherichia coli, Proteus mirabilis, Serratia marcescens, Enterobacter species, Pseudomonas aeruginosa, Klebsiella pneumoniae, and Citrobacter species. Intra abdominal Infections, including peritonitis caused by Escherichia coli, Klebsiella species including K. pneumoniae, Enterobacter species including E. cloacae, Pseudomonas aeruginosa, Citrobacter species including C. freundii, and Serratia species including S. marcescens. Gynecologic Infections, including endometritis and pelvic cellulitis caused by Escherichia coli, Klebsiella pneumoniae, Enterobacter species including E. cloacae, and Proteus mirabilis. Aztreonam for Injection is indicated for adjunctive therapy to surgery in the management of infections caused by susceptible organisms, including abscesses, infections complicating hollow viscus perforations, cutaneous infections, and infections of serous surfaces. Aztreonam for Injection is effective against most of the commonly encountered Gram negative aerobic pathogens seen in general surgery.

Resumo do produto:

Visual Identification: Off white to slightly yellowish lyophilized powder or cake; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 24 Months; Container Temperature: Store between 20 - 25 degrees celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Status de autorização:

Listed (Export Only)

Data de autorização:

2021-11-30